ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SIGA vs ELDN // ALTMAN Z-SCORE & DEBT/EQUITY

SIGA Technologies Inc. (NASDAQ) VS. Eledon Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: SIGA 2 — ELDN 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIGA VS. ELDN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SIGA ELDN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 42.70% -35.00% +77.70 SIGA /roic <GO>
EV/EBITDA & P/E Valuation 4.8x — — TIE /valuation <GO>
Free Cash Flow Yield 19.03% — — TIE /fcf-yield <GO>
Operating Margin 25.10% — — TIE /operating-margins <GO>
Net Profit Margin 24.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) -31.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 8.22 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 1/9 +5.00 SIGA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.8 51.0 -11.20 ELDN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 9.1x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $212.0M $212.9M -$947.6K ELDN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SIGA REV ELDN REV SIGA GROSS % ELDN GROSS % SIGA FCF ELDN FCF
FY 2025 $94.6M $71.0M 68.6% — $43.5M -$62.3M
FY 2024 $138.7M $74.5M 77.4% — $48.8M -$47.3M
FY 2023 $139.9M $120.4M — — $94.8M -$39.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIGA // BETA —
ELDN // BETA —